Bionest

Driving CAR-T beyond oncology

Several companies and research institutions are developing potential CAR-T treatments for non-cancer indications, from heart disease to viral infection.

Bionest

ESMO 2019: Translating Science into Better Cancer Care

The field of oncology has seen a number of significant advances in recent years. The considerable number of positive reports from the 2019 Congress of the European Society for Medical Oncology (ESMO) last month clearly reflected the meeting’s theme — the translation of scientific advances into better cancer care.   AstraZeneca/Merck was one of stars...

Bionest

Psychedelic Drug Research Making a Comeback

In the 1950s and early 1960s, researchers within both academic and governmental institutions extensively investigated the clinical potential of psychedelic drugs, notably both LSD and psilocybin, the psychoactive substance in “magic mushrooms.” This early research aimed to understand the biological underpinnings of schizophrenia and to find new treatments for psychological disorders such as depression, anxiety...